Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Report Overview
2023
Base Year
2018-2023
Historical Year
2024-2032
Forecast Year
Competitive Landscape
The report gives an in-depth analysis of the key players involved in the global peripheral neuropathy treatment market, sponsors manufacturing the therapies, and putting them through trials to get FDA approvals. The companies included in the market are as follows:
- Abbott Laboratories
- Bristol Myers Squibb Co
- Novartis AG
- Eli Lilly and Company
- Pfizer Inc.
- GlaxoSmithKline Plc
- Merck and Co. Inc.
- F. Hoffmann-La Roche Ltd
- Cipla Ltd.
- Lupin Ltd
- Dr. Reddy’s Laboratories
- RxFunction, Inc.
Peripheral Neuropathy Treatment Market Report Snapshots
Peripheral Neuropathy Treatment Market Size
Peripheral Neuropathy Treatment Market Growth
Peripheral Neuropathy Treatment Companies
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Looking for specific insights?
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Key Questions Answered in the Report
The market attained a value of USD 764.27 million in 2023.
The market is likely to grow at a CAGR of 3.7% during the forecast period of 2024-2032.
The market is expected to reach a value of USD 1,059.88 million by 2032.
The rising prevalence of chronic diseases, such as diabetes, cancer, and hypothyroidism, increases the risk of peripheral neuropathy in chronic disease patients.
The major regional markets include North America, Europe, Latin America, Middle East and Africa, and Asia Pacific.
The major types include diabetic, chemotherapy-induced, idiopathic, and HIV/AIDS associated peripheral neuropathy.
The key players in the market include Abbott Laboratories, Bristol Myers Squibb Co, Novartis AG, Eli Lilly and Company, Pfizer Inc., GlaxoSmithKline Plc, Merck and Co. Inc., F. Hoffmann-La Roche Ltd, Cipla Ltd., Lupin Ltd, Dr. Reddy’s Laboratories, and RxFunction, Inc., among others.
High product costs, availability of alternative treatments, and stringent regulatory compliance and device recalls, are major factors impeding the market growth.
Purchase Full Report
Datasheet
- Selected Sections, One User
- Printing Not Allowed
- Email Delivery in PDF
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next Update
Single User License
One User
- All Sections, One User
- One Print Allowed
- Email Delivery in PDF
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next Update
Five User License
Five Users
- All Sections, Five Users
- Five Prints Allowed
- Email Delivery in PDF
- Free Limited Customisation
- Post Sales Analyst Support
50% Discount on Next Update
Corporate License
Unlimited Users
- All Sections, Unlimited Users
- Unlimited Prints Allowed
- Email Delivery in PDF + Excel
- Free Limited Customisation
- Post Sales Analyst Support
- 50% Discount on Next Update
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Subscribe to our Newsletter
By subscribing you agree to with our privacy policy and provide
consent to
receive
updates
from our company.
Our Offices
Australia
63 Fiona Drive, Tamworth, NSW
+61 448 06 17 27
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63 287899028, +63 967 048 3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84865399124